Back to Journals » Drug Design, Development and Therapy » Volume 15

Review

Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia

         
Total article views   Abstract views HTML views PDF downloads Totals
1,691 Dovepress* 883 808+ 261 1,691
Totals 883 808 261 1,691
*Since 2 March 2021
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 1 4 7

View citations on Google Scholar